A Difficult Challenge for the Clinical Laboratory: Accessing and Interpreting Manufacturer Cross-Reactivity Data for Immunoassays Used in Urine Drug Testing
Urine drug testing by immunoassay is widely used to detect nonmedical drug use and to monitor patients prescribed controlled substances. A key attribute of urine drug testing immunoassays is cross-reactivity, namely the response of various compounds compared to the target of the assay. In this repor...
Saved in:
Main Authors: | Justine M. Reschly-Krasowski (Author), Matthew D. Krasowski MD, PhD (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2018-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Educational Case: Regulatory Issues With Laboratory Testing
by: Matthew D. Krasowski MD, PhD
Published: (2019) -
Educational Case: Hemolysis and Lipemia Interference With Laboratory Testing
by: Matthew D. Krasowski MD, PhD
Published: (2019) -
Educational Case: Ethylene Glycol Poisoning
by: Matthew D. Krasowski MD, PhD
Published: (2020) -
Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications
by: Matthew D. Krasowski
Published: (2010) -
Academic E-Mail Overload and the Burden of "Academic Spam"
by: Kelly E. Wood MD, et al.
Published: (2020)